Emgality 120 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FXNG7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,348
Award facts
- Contract value 100% obligated
- $3,348.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,348.00 to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of November 26, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems, providing a comprehensive range of medications and medical supplies.
Emgality (erenumab) is a monoclonal antibody approved for migraine prevention and represents a specialized therapeutic medication within AmerisourceBergen's broad pharmaceutical portfolio supplied to federal customers. As a major pharmaceutical distributor with demonstrated capability to fulfill federal procurement requirements, AmerisourceBergen continues to support the Defense Health Agency and military healthcare programs through its global pharmaceutical prime vendor agreement, which enables flexible fulfillment of medical supply needs across multiple therapeutic domains including neurological treatments, pain management, and specialty medications.
Quick answers
Who was awarded contract SPE2DR26FXNG7?
SPE2DR26FXNG7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FXNG7 worth?
The government has obligated $3,348 on SPE2DR26FXNG7.
Is contract SPE2DR26FXNG7 an order under another contract?
Yes. SPE2DR26FXNG7 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXNG7 competed?
The extent of competition for SPE2DR26FXNG7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award